Talledo, Remedios M.
HRN: 25-45-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2024
CEFTRIAXONE 1G (VIAL)
07/09/2024
07/16/2024
IV
2 Gram
Q24 Hours
CAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes